Merck MRK
NYSE MRK
$152.55 +3.56 (+2.39%)
At close: Aug 21, 2026 · 4:01 PM EDT

Merck (MRK) Cash from Discontinued Operations (2020 - 2021)

Merck (MRK) posted quarterly Cash from Discontinued Operations of 64000000.0 for Q4 2021, down 110.74% year-over-year from 596000000.0 in Q4 2020, and down 112.8% quarter-over-quarter from 500000000.0 in Q2 2021.

Merck (MRK) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends

Merck (MRK) has reported Cash from Discontinued Operations for 2 consecutive years, with 64000000.0 the latest figure, recorded in Q4 2021.

  • In Q4 2021, Cash from Discontinued Operations fell 110.74% year-over-year to 64000000.0; the TTM figure through Sep 2022 stood at 64000000.0 (down 103.89% YoY), while the FY2021 annual figure was 987000000.0, down 62.56% from the prior year.
  • Cash from Discontinued Operations fell to 64000000.0 in Q4 2021 per MRK's latest filing, from 500000000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 596000000.0 in Q4 2020 and bottomed at 64000000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 3.61 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -64.00 Mn
Dec 31, 2021 -64.00 Mn
Jun 30, 2021 500.00 Mn
Jun 30, 2021 500.00 Mn
Mar 31, 2021 551.00 Mn
Mar 31, 2021 551.00 Mn
Dec 31, 2020 596.00 Mn
Dec 31, 2020 596.00 Mn
Sep 30, 2020 591.00 Mn
Sep 30, 2020 591.00 Mn